About Us
Farmson was established in the year 1969 for manufacturing of Paracetamol through phenol route. In the year 2000, we switched over to the PNCB route to manufacture Paracetamol. Currently, we are the GLOBAL LEADER in API Paracetamol production.
With the motto of self-reliance, in 2005, we set up a plant in Jhagadia-Bharuch with backward integration for manufacturing of PAP from PNCB wherein we were the first and only company producing PAP through Hydrogenation process. For manufacturing API Paracetamol, we commissioned Unit-II in 2012, while in 2018, Unit-I was renovated & restructured to further expand our capacity.
Today, We Are
Manufacturing 52000 MTPA
Having presence in 60+ countries
Backwardly integrated for PAP
Forward integration for DC
Only Paracetamol Manufacturer with RC Logo (2023)
Having total Global Market share of 22%
Having total Domestic Market share of 50%
Paracetamol, being the safest & the most affordable Analgesic & Antipyretic drug, is used for treating fever, flu, body pain and cold.
Our DC provides drum-to-feeder compression/encapsulation solutions that are both economically sound and operationally simple.
Introducing Our Latest API Range from Units 4 & 5
Late Mr. K.K. VITHANI
Our Visionary
Founder | Mentor | Guide
Truly a great mentor who inspired us to practice innovations
“Quality extends well beyond our product. It is ingrained in everything we do and reflects our total commitment to our customers”
Total Quality Management
Good Manufacturing Practices
Complete Customer Delight
Updated Indigenous Technology
Research Orientation and Team Work
Single Product Policy with dedicated manufacturing units
Large Production Capacity
Message from the Chairman
“For over 50 years, Farmson has led the way in Paracetamol API, built on trust, quality, and innovation.
As we grow, we’re expanding into new APIs and sustainable practices—driven by our people, partners, and purpose.
Thank you for being part of our journey.”
Vision for the Future
CEO, Farmson Basic Drugs
At Farmson Basic Drugs, we’ve built a legacy of trust and quality. As we strengthen our leadership in Paracetamol APIs, my vision is to drive Farmson forward—expanding into high-demand molecules and integrated solutions that meet the needs of a dynamic global market.
Rural Development
Beneficiaries 2 Initiatives
Skill Development
Beneficiaries 2 Initiatives
Animal Care
Beneficiaries 1 Initiatives
Environment Care
Beneficiaries 1 Initiatives
Farmson basic drug csr Initiatives:
Our state-of-the-art R&D facility specializes in developing cost-effective, eco-friendly APIs through multi-scale synthesis from grams to kilograms. With expert scientists focused on analgesics, CNS stimulants, and anti-diabetic drugs, our lab features advanced equipment like Autoclaves, Reactors, Vacuum Tray Dryers, HPLC, UPLC, GC, FTIR, and more.
Dive InOur Insights
Catch up on the latest from Farmson. Explore our expert insights and see what’s new in the world of Farmson..
Life At Farmson
Join USThe future of everyday health is changing and we're the people changing it.
Nowhere else will you find an opportunity quite like this.
Our Facilities
Unit I
Plot No. 28–35, GIDC Industrial Estate, Nandesari, Vadodara – 391340, Gujarat. Capacity: 28,000 MTPA
Unit II
Plot No. 14, GIDC Industrial Estate, Nandesari, Vadodara – 391340, Gujarat. Capacity: 3,600 MTPA (DC Grade) + 24,000 MTPA (API)
Unit III
Plot No. 748/1, GIDC, Jhagadia, Bharuch – 393110, Gujarat. Capacity: 45,000 MTPA
Unit IV
Plot No. 105 GIDC Industrial Estate, Nandesari, Vadodara - 391340 Capacity: Plot No. 105 GIDC Industrial Estate, Nandesari, Vadodara - 391340
Unit V
Dp-146, Dp-148 GIDC Industrial Estate, Saykha,
Bharuch-392140 Capacity: 43,200 MTPA
Unit VI
130, 131, GIDC Ind. Estate, Nandesari, Dist. Vadodara 391340, Gujarat, India Capacity: 43,200 MTPA